Cellply vs Ray Therapeutics

Cellply vs Ray Therapeutics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cellply is on 52/100 and Ray Therapeutics on 53/100.

CellplyDeepTech startup developing analytical tools for characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics.
Ray Therapeutics logo
Ray TherapeuticsPioneering vision restoration therapies for severe retinal degenerations.
Try Ray Therapeutics

Where each one leads

Cellply

Leads on none of the measures we hold for both companies.

Ray Therapeutics

  • funding raised: $243M against $7.2M

At a glance

MeasureCellplyRay Therapeutics
What it isDeepTech startup developing analytical tools for characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics.Pioneering vision restoration therapies for severe retinal degenerations.
CategoryBiotechnology, HealthTech, Artificial Intelligence, Medical DevicesBiotechnology, Pharmaceuticals, Healthcare, Medical Devices
Sells toBusiness modelB2BB2B
OfferingHardwareServices
Founded20132021
HeadquartersBologna, ItalyBerkeley, USA
StatusActiveActive

Size, funding and growth

MeasureCellplyRay Therapeutics
Employees25Not published
Total funding$7.2M$243M
Latest roundFunding RoundSeries B
LinkedIn followers9,134Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCellplyRay Therapeutics
StartupHub scoreOur 0-100 rating52/10053/100
Traction48/10040/100
Team60/10050/100
Community15/100Not published
Search visibility33/10014/100
Quality58/10068/100
Agent readinessHow well an AI agent can read and act on the siteNot publishedF (21/100)
Domain ratingLink authority, 0-100Not published29/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCellplyRay Therapeutics
CDNNot detectedCloudflare
CMSNot detectedWordPress
FrameworksNot detectedJquery
AnalyticsNot detectedGoogle Analytics 4

Cellply vs Ray Therapeutics: common questions

Which is better, Cellply or Ray Therapeutics?

On our 0-100 score Ray Therapeutics rates higher (53/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.

How do Cellply and Ray Therapeutics compare on the numbers?

Ray Therapeutics leads on funding raised ($243M against $7.2M).

Read the full Cellply review and pricing or the Ray Therapeutics review and pricing. You can also browse other Cellply alternatives we track.